Target intelligence / Profile preview

Human leukocyte antigen A*02:01 (HLA-A*02:01) (HLA-A*02:01)

Target
HLA-A*02:01
Molecular classification
Major histocompatibility complex class I (MHC class I)
01

Overview

Human leukocyte antigen A*02:01 (HLA-A*02:01) is a specific allele of the HLA-A gene encoding an MHC class I molecule on chromosome 6p21.3. It forms a heterodimer with β2-microglobulin, featuring a peptide-binding groove between antiparallel α1 and α2 helices supported by an eight-stranded β-sheet, plus an α3 domain for CD8 binding. It presents endogenous peptides (typically 8-10 mers with anchors like Val at P2 and Leu/Val at C-terminus) to CD8+ T cells for adaptive immunity. Polymorphisms in pockets A-F determine peptide specificity, e.g., preferring L/M/I at P2 and V/L/I/A at PΩ. Common in populations, it influences viral clearance (e.g., HCV, HIV), cancer immunotherapy, and transplant matching, with crystal structures confirming typical MHC class I fold (e.g., RMSD 0.415 Å to other complexes).

Other names
HLA-A*02HLA-A2A*02
02

Mechanism of action

Peptide binding in antigen-binding groove for T cell receptor recognition, Safety switch in CAR-T therapy via allelic specificity

03

Biological functions

Antigen presentationImmune responseT cell recognition
04

Disease associations

CancerInfectionTransplant rejection
05

Safety considerations

Organ transplant rejection due to polymorphismPotential immune escape in viral infectionsCross-reactivity with HLA-A*69 in blockers
06

Interacting drugs

HLA-A*02-directed blocker (PA2.1-derived)

1 more in the full profile.

07

Biomarkers

HLA-A*02:01 typing for patient selection in immunotherapyTissue typing marker

Beyond the preview

Go deeper on Human leukocyte antigen A*02:01 (HLA-A*02:01) (HLA-A*02:01).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human leukocyte antigen A*02:01 (HLA-A*02:01) (HLA-A*02:01).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call